MWP
ITCI

MYCIO Wealth Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

MYCIO Wealth Partners’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,398
Closed -$67K – 695
2016
Q3 		$67K Hold
4,398
– – 0.01% 301
2016
Q2 		$171K Buy
4,398
+550
+14% +$19.8K 0.03% 194
2016
Q1 		$107K Buy
3,848
+1,721
+81% +$57.4K 0.02% 221
2015
Q4 		$114K Hold
2,127
– – 0.02% 201
2015
Q3 		$85K Hold
2,127
– – 0.02% 228
2015
Q2 		$68K Buy
+2,127
New +$53.9K 0.01% 263

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MYCIO Wealth Partners's ITCI Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2016, closing a stake of 4,398 shares — an estimated $67K sold.

MYCIO Wealth Partners first reported a position in ITCI in Q2 2015 and held it in 6 quarters. The position peaked at $171K in Q2 2016. 129 funds tracked by Wall St. Rank hold ITCI as of Q4 2016.

  • MYCIO Wealth Partners reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2016 after selling out during the quarter.
  • MYCIO Wealth Partners sold 4,398 Intra-Cellular Therapies Inc. shares in Q4 2016, an estimated $67K.
  • MYCIO Wealth Partners first reported a position in Intra-Cellular Therapies Inc. in Q2 2015 and held it in 6 quarters.
  • MYCIO Wealth Partners's Intra-Cellular Therapies Inc. position peaked at $171K in Q2 2016.
  • 129 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.